| Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome
Direct transfer of NADH between a-glycerol phosphate
Effectiveness of NADH in alleviating effects of sleep deprivation
Effects of Extracellular NADH on Human Tumor Cell Proliferation
ENADA NADH improves cognitive impairment of Alzheimer patients
Engineering of a functional human NADH-dependent cytochrome P450
Extracellular metabolisation of NADH by blood cells correlates with intracelular ATP levels
Fluorescence lifetime imaging of free and protein-bound NADH
NAD+ and NADH regulate an ATP-dependent kinase
NADH a new therapeutic approach to parkinsons disease
NADH energizes mental and physical performance
NADH in cancer prevention and therapy
NADH NAD redox state of cytoplasmic glycolytic
NADH sensor of blood flow need in brain
NADH supplementation decreases pinacidil primed ATP
On the safety of reduced NADH
Oral reduced B-NADH affects blood pressure
Parenteral appl. of NADH in Parkinson's desease
Reduced Co-Enzyme 1 (NADH) Improves Psychomotric and Physical performance in Athletes
Reduced Coenzyme Nicotinamide Adenine Dinucleotide (NADH) repairs DNA damage of PC12 Cells induced by doxorubicin
The antioxidative capacity of nadh in humans
The Coenzyme Nictinamide Adenine Dinucleotide (NADH) as Biological Antidepressive Agent Experience with 205 Patients
The reduced coenzyme NADH prevents hepatic cells from apoptosis
por Alberto Manuel Coelho de Sousa Pinto (ENADA) (Sexta 30 Novembro, 2012)
Enada: Será que é mesmo nada?
- Não me parece, e passo a explicar porquê:
Há uns três anos atrás, pensava que pertencia ao grupo dos hibernantes, assim como os ursos, que dormem durante todo o o Inverno; bastava almoçar ou jantar e, imediatamente, começava a dormir como um justo!...
|
